Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells

NCT04382547 is registered in ClinicalTrials.gov with Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus as lead sponsor.

NCT NCT04382547
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04382547 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells
Lead sponsor
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
Phase
Phase 1/2
Overall status
Completed
Start date
May 11, 2020
Completion date
June 30, 2021
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus, covid, covid-19, pneumonia, pneumonia, interstitial, pneumonia, viral, sars-cov2